Misato, Japan

Kiyosato Nyu


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1978-1980

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kiyosato Nyu: Innovator in Anti-Inflammatory Compounds

Introduction

Kiyosato Nyu is a notable inventor based in Misato, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory compounds. With a total of 3 patents to his name, Nyu's work has garnered attention for its potential therapeutic applications.

Latest Patents

Nyu's latest patents include innovative compounds such as Benzo[b,f]thiepan derivatives, specifically 9-(.beta.-hydroxyethyl) piperazinyl-carbonyl-2-trifluoromethyl-10, 11-dihydrodibenzo[b,f]thiepin. This compound has been disclosed as having anti-inflammatory action. Another significant patent involves Benzo[b,f]thiepin derivatives and the process for producing the same. These novel derivatives possess strong anti-inflammatory action while presenting few adverse reactions. The formula includes various substituents that enhance the compound's efficacy, making it a valuable addition to pharmaceutical compositions.

Career Highlights

Kiyosato Nyu is associated with Nippon Chemiphar Co., Ltd., where he has been instrumental in advancing research and development in pharmaceutical sciences. His work focuses on creating compounds that can effectively treat inflammation, a common and debilitating condition.

Collaborations

Nyu has collaborated with esteemed colleagues such as Shigeru Yamabe and Yasuo Fujimoto. Their combined expertise has contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Kiyosato Nyu's contributions to the field of anti-inflammatory compounds highlight his role as a significant inventor in the pharmaceutical industry. His patents reflect a commitment to improving health outcomes through innovative research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…